GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.

GlycoEra AG

GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body.  Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.

Sofinnova Partners

5AM Ventures

LimmaTech Biologics

Roche Venture Fund

Bristol Myers Squibb

We are thrilled to announce Santiago Arroyo, MD has joined our Board of Directors.  Dr. Arroyo brings a great deal of experience and clinical insights to help drive our science and platform to the next level.
#proteindegradation #science #degradation #experience

We kicked off the new year with a new home in Switzerland.  #proteindegradation #degradation

Are you attending BIO Partnering at JPM Week? Click below to send GlycoEra a meeting request in the BIO partnering system! #JPM2023 
 
https://lnkd.in/e2kAphtA

Are you attending JPM in San Francisco in January....we certainly are! Our team is looking forward to connecting with colleagues old and new. Reach out to Ganesh Kaundinya, Tanmoy Ganguly or Tanya Saggese if you want to get together. #jpm2023 #jpm23 #extracellular #circulating #JPMHC23 #proteindegradation

Schlieren, Switzerland - October 25, 2022 - GlycoEra will be presenting exciting data in Basel, Switzerland at the Festival of Biologics on November 3rd at 6 pm CET.  #biotechnology #proteindegradation #glycans

Newton, Mass. – October 20, 2022 – GlycoEra AG, a biotechnology company building a high-value pipeline of medicines based on deep expertise in protein degradation and glycobiology, today announced it will be presenting at the 5th Annual TPD Targeted Protein Degradation Conference, held October 25-28 at the DoubleTree by Hilton Hotel Boston North Shore, Danvers MA.  #biotechnology #tpd #proteindegradation #glycans

COM:GLYCOERA

GlycoEra AG

Financials Not Available